All News about Merck & Co
Analyst Reiterates This Alzheimer's Candidate As Top Idea For 2023
February 08, 2023
Via Benzinga
Via Benzinga
Should Investors Buy or Sell the Vaccinex Patent News?
February 07, 2023
Via MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
Analyst Upgrades Personalis; Says Biopharma Is Strong, Cash Burn Is Down
February 06, 2023
Via Benzinga
Merck & Co Earnings Preview
February 01, 2023
Via Benzinga
Why Personalis Shares Are Trading Higher Today
February 03, 2023
Via Benzinga
Merck Announces Fourth-Quarter and Full-Year 2022 Financial Results
February 02, 2023
From Merck & Co., Inc.
Via Business Wire
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|